Utilizing my experience in synthetic chemistry and chemical biology from my graduate studies, I am working alongside Senotherapeutix, Inc. and DELiver Therapeutics, Inc. to develop novel therapeutics involved in the development and progression of cancer and aging in a variety of areas. I pride myself in my ability to learn new techniques efficiently and to adapt to new situations as our companies transmutes to new discoveries. Through DNA-encoded libraries (DELs), thousands of novel drug candidates can be easily obtained and characterized compared to traditional high throughput screening methods. Within one year, I am conducting all cellular assays at Senotherapeutix while also assisting with in silico drug discovery through molecular docking. I also design, synthesize, characterize, and test DNA-encoded therapeutics for their ability to disrupt a variety of protein active sites involved in cancers and aging and aid in the synthesis of small molecule therapeutics for in vitro and in vivo testing. Our newest projects are involved with improving the effects and side effects of semaglutides for weight loss treatment. I m leading the method development process for the quantification of our weight loss therapueitcs via LCMS. Senotherapeutix and DELiver Therapeutics have allowed me to expand and refine my scientific skill set, and I find joy in learning new aspects of chemistry and in the challenge of becoming an expert.More...
Lydia C
Compliance Specialist@Aspida
Verified
Compliance Specialist at a rapidly growing company focused on protecting clients’ financial goals through annuities.
3 years of experience in administrative duties, call center responsibilities and small office management and recruiting.
Detail-oriented, people person, comfort enthusiast, positivity spreader.More...